Latest Articles
Preetam Jain: Personalized Endometrial Cancer Treatment Based on 4 Key Molecular Subgroups - Oncodaily
Preetam Jain: Personalized Endometrial Cancer Treatment Based on 4 Key Molecular Subgroups Oncodaily
Published: June 22, 2026, 4:56 a.m.
The rising burden of endometrial cancer in Jamaica - Jamaica Observer
The rising burden of endometrial cancer in Jamaica Jamaica Observer
Published: June 21, 2026, 5:05 a.m.
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial - MSN
MSD’s sac-TMT meets primary endpoints in Phase III endometrial cancer trial MSN
Published: June 21, 2026, 4:52 a.m.
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer - OncLive
Dostarlimab Provides Long-Term Benefits in dMMR/MSI-H Endometrial Cancer OncLive
Published: June 20, 2026, 1:04 p.m.
How AI imaging technique detects early endometrial cancer with accuracy - Medical Buyer
How AI imaging technique detects early endometrial cancer with accuracy Medical Buyer
Published: June 20, 2026, 10:17 a.m.
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer - OncLive
Nivolumab Produces 68% Clinical CR Rate in Resectable dMMR Endometrial Cancer OncLive
Published: June 19, 2026, 5:49 p.m.
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer - Targeted Oncology
Puxitatug Samrotecan Hits 60% Response Rate in Platinum- and IO-Pretreated Endometrial Cancer Targeted Oncology
Published: June 19, 2026, 5:05 p.m.
Quick optical biopsy could be early detection method for endometrial cancer - Medical Xpress
Quick optical biopsy could be early detection method for endometrial cancer Medical Xpress
Published: June 19, 2026, 3:40 p.m.
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... - Medical Dialogues
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... Medical Dialogues
Published: June 19, 2026, 2:30 p.m.
Palbociclib Plus Anastrozole Is Safe and Effective in ER+ Recurrent Endometrial Cancer - OncLive
Palbociclib Plus Anastrozole Is Safe and Effective in ER+ Recurrent Endometrial Cancer OncLive
Published: June 19, 2026, 1:08 p.m.
Link copied to clipboard!